Stockrabit · Analysts
Questions across 2 calls

Amey Chalke

JM Financial Services

Anthem Biosciences Limited

Anthem Biosciences Limited CC-May26.pdf · 2026-05-20
Sure. Thank you for giving me opportunity. I have first question on CRO about how it has done during the year and the quarter, and if we can provide t he breakup? Also, along with that, the GMs have gone up over last one year as well as this quarter or the second half, it is consistently above 65%. Is it contributed by the higher CRO mix and what is the outlook over there?
Thank you so much. One question I have for Ajay, in CRO; AI companies are also started coming in in the US market. Although , we are fortunately more manufacturing company, but how do you see this AI evolution in the CRDMO space? Do you think that there is any space for this AI coming into the manufacturing side of it, which can be a material advantage on the AI?

Fortis Healthcare Limited

Fortis Healthcare Limited CC-Sep24.pdf · 2024-11-08
Congrats to the management for the good numbers. The first question I have on the margins, especially hospital margins, we have been -- like this is second quarter, we have clocked more than 20% margins. Margins are improving consistently sequentially. This is even before our brownfield expansion initiatives are yet to kick in. So what are the key levers here? If you can call out any specific hospitals which have helped deliver improvement in margins over the last 6 months?
Sure. Is it possible to tell which two hospitals have moved to the 20% to 25% range during this quarter?